Dealwatch: Sullivan & Cromwell’s City office and CC advise on nearly £6bn worth of deals

Legal Business · 9 September 2015 · 2 min read

Corporate and M&A Corporate Clifford Chance Linklaters Skadden, Arps, Slate, Meagher & Flom Sullivan & Cromwell

Sullivan & Cromwell’s City office has been busy this summer winning roles on two headline deals announced yesterday [8 September], working alongside Clifford Chance (CC) on both Cinven’s £2.3bn sale of pharmaceuticals group Amdipharm Mercury Company (AMCo) and advising Goldman Sachs on Mitsui Sumitomo’s £3.5bn Amlin purchase.

This article is for Legal Business subscribers. Please log in or subscribe to read on.

Related Content

Trading Places: Paul Weiss launches in Silicon Valley as Simpson Thacher builds out new Chicago office

Clifford Chance makes major US sports play with hire of Sidley practice co-chair

GSK recruits new legal chief as long-serving GC prepares to step down

Cravath makes rare London partner promotion amid 11-strong round

Sidley in talks to take Weil Paris office alongside heavyweight PE partners in London and Germany

Slaughters leads for Anthropic on UK share offer in IPO

Dealwatch: Baker McKenzie and Gibson Dunn lead on $5bn data centre investment while US trio orchestrate $27bn energy deal

‘There’s a lot of money in Chicago’ – the city’s top lawyers on what’s driving business in the Midwest

Cleary and White & Case switch on for Canal+ £2.5bn IPO in London